Acerus Pharmaceuticals Corporation ASP-CA:Toronto Stock Exchange

*Data is delayed | CAD
Last | 06/18/21 EDT
0.045quote price arrow down-0.005 (-10.00%)
Volume
144,548
52 week range
0.03 - 0.07

...

Loading . . .
  • Open0.05
  • Day High0.05
  • Day Low0.045
  • Prev Close0.05
  • 52 Week High0.07
  • 52 Week High Date02/10/21
  • 52 Week Low0.03
  • 52 Week Low Date11/24/20

Key Stats

  • Market Cap57.04M
  • Shares Out1,537.59M
  • 10 Day Average Volume69,047.67
  • Dividend-
  • Dividend Yield-
  • Beta0.97
  • YTD % Change12.5

KEY STATS

  • Open0.05
  • Day High0.05
  • Day Low0.045
  • Prev Close0.05
  • 52 Week High0.07
  • 52 Week High Date02/10/21
  • 52 Week Low0.03
  • 52 Week Low Date11/24/20
  • Market Cap57.04M
  • Shares Out1,537.59M
  • 10 Day Average Volume69,047.67
  • Dividend-
  • Dividend Yield-
  • Beta0.97
  • YTD % Change12.5

RATIOS/PROFITABILITY

  • EPS (TTM)-0.03
  • P/E (TTM)-1.34
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Acerus Pharmaceuticals Corporation

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Acerus Pharmaceuticals Corporation, formerly Trimel Pharmaceuticals Corporation, is a Canada-based pharmaceutical company. The Company is engaged in the development, manufacture, marketing and distribution of products with a focus on men's health, including urology, and women's health, including hormone replacement therapy and female sexual dysfunction. The Company markets Estrace in Canada, which is an oral, plant-derived 17-beta estradiol therapy for the relief of symptoms...
Ian Ihnatowycz
Chairman
Edward Gudaitis
President
Robert Motz
Chief Financial Officer
Philippe Savard
Vice President
Address
2486 Dunwin Drive
Mississauga, ON
L5L 1J9
Canada

Top Peers

SYMBOLLASTCHG%CHG
ACST
Acasti Pharma Inc
0.5049-0.0206-3.9201%
OPNT
Opiant Pharmaceuticals Inc
13.90+0.08+0.58%
CPH
RX
MRV
Nuvo Pharmaceuticals Inc
1.42UNCHUNCH